3746 - Prescription Drugs: Costs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what discussions he has had with (a) university research and development departments and (b) pharmaceuticals companies on reducing the cost of NHS-prescribed medicines.

George Freeman

Regular discussions take place with a full range of stakeholders concerning both the pricing of branded medicines and accelerating patient access to innovative medicines.